Orthofix Medical Inc (OFIX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OFIX Annual Cash Flow →
Examining cash flow movements between Orthofix Medical Inc and Mar 31 2025 reveals how Mar 31 2026 allocates cash as operating conditions evolve.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
3 Months
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-20.91
Depreciation & amortization13.49
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.75
Provision For Loan Losses Expensed0.72
Increase (Decrease) in Inventories8.85
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.33
Share-based Compensation6.53
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities0.90
Debt Refinancing Charge-
Gain Loss On Derivative Instruments Net Pretax-
Depreciation Depletion And Amortization Including Portion From Discontinued Operations-
Amortization Of Exclusivity Agreements-
Goodwill And Intangible Asset Impairment-
Employee Service Share Based Compensation Tax Benefit From Compensation Expense-
Amortization Of Debt Costs And Other Assets-
Gain On Valuation Of Equity Securities-
Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings-
Gain Loss On Valuation Of Equity Securities-
Amortization Of Lease Assets Debt Costs And Other Assets1.06
Inventory Reserve Expenses2.90
Change In Valuation Of Investment Securities-0.02
Payment For Contingent Consideration Liability Operating Activities-
Income taxes0.09
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net-0.02
Increase (Decrease) in Accounts Receivable2.96
Increase (Decrease) in Accounts Payable-4.37
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-5.22
Other Noncash Income (Expense)0.18
Other net0.00
Payments for (Proceeds from) Other Operating Activities12.03
Discontinued operations0.00
Net Cash flow from Operating Activities-17.61
Investing Activities
Capital Expenditures10.66
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Payment Related To Collaborative Arrangement-
Proceeds From Sale Of Discontinued Operations-
Proceeds From Sale Of Subsidiary-
Net Cash Proceeds From Sale Of Subsidiary-
Contingent Consideration Payments Related To Asset Acquisitions-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Payments to Acquire Additional Interest in Subsidiaries0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.15
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-10.52
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.02
Long-term debt - borrowings64.03
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-85.12
Repurchase And Retirement Of Common Shares-
Finance Lease Principal Payments-0.03
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations85.12
Contingent Consideration Milestone Payment-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities63.97
Effect of exchange rate on cash flow-0.09
Discontinued operations0.00
Free Cash Flow-6.95
Total Cash Flow35.76
4 historic quarters locked

Sign in to unlock the full Orthofix Medical Inc cash flow history.

About Orthofix Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-333822

Figures are derived from filed reports and may be restated. Historical data is subject to revision.